Anticardiolipin antibodies in acute non-hemorrhagic stroke seen within six hours after onset
- 29 January 2009
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 92 (1) , 69-71
- https://doi.org/10.1111/j.1600-0404.1995.tb00469.x
Abstract
We have undertaken a prospective study to measure anticardiolipin antibodies of IgG isotype within the first few hours of an acute non-hemorrhagic stroke.We have collected blood samples at entry from one hundred patients (53 men and 47 women), mean age 67.4 years, referred within 6 h of a first-ever non-hemorrhagic stroke, and from an equal number of age- and gender-matched control patients.IgG anticardiolipin antibodies were > or = 10 GPL in 26 patients and in 5 controls (p < 0.0001, X2 test). After logistic regression analysis, increase of IgG anticardiolipin antibodies remained independently associated with stroke (p = 0.0034), together with hypertension (p = 0.0009) and atrial fibrillation (p = 0.0238).Our data suggest that the occurrence of elevation of IgG anticardiolipin antibodies in stroke patients should antedate stroke onset and might be a risk factor per se.Keywords
This publication has 6 references indexed in Scilit:
- Anticardiolipin antibodies are an independent risk factor for first ischemic strokeNeurology, 1993
- Anticardiolipin antibodiesNeurology, 1991
- Cerebrovascular and neurologic disease associated with antiphospholipid antibodiesNeurology, 1990
- Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE DisordersAnnals of Internal Medicine, 1990
- Prospective study of anticardiolipin antibodies in stroke.Stroke, 1990
- The Stroke Data Bank: design, methods, and baseline characteristics.Stroke, 1988